AAAAAA

   
Results: 1-15 |
Results: 15
GEOGRAPHICAL EPIDEMIOLOGY OF OVARIAN AND TESTICULAR GERM-CELL CANCERS
Authors: KAMDAR RH OLIVER RTD OTHIENOABINYA N GALLAGHER CJ SLEVIN ML
Citation: Rh. Kamdar et al., GEOGRAPHICAL EPIDEMIOLOGY OF OVARIAN AND TESTICULAR GERM-CELL CANCERS, British Journal of Cancer, 78(11), 1998, pp. 1401-1401
CHEMOTHERAPY FOR OVARIAN-CANCER - A CONSENSUS STATEMENT ON STANDARD PRACTICE
Authors: ADAMS M CALVERT AH CARMICHAEL J CLARK PI COLEMAN RE EARL HM GALLAGHER CJ GANESAN TS GORE ME GRAHAM JD HARPER PG JAYSON GC KAYE SB LEDERMANN JA OSBORNE RJ PERREN TJ POOLE CJ RADFORD JA RUSTIN GJS SLEVIN ML SMYTH JF THOMAS H WILKINSON PM
Citation: M. Adams et al., CHEMOTHERAPY FOR OVARIAN-CANCER - A CONSENSUS STATEMENT ON STANDARD PRACTICE, British Journal of Cancer, 78(11), 1998, pp. 1404-1406
A PHASE-II STUDY OF INTERFERON ALPHA-2A (IFN-ALPHA) AND MODULATED 5-FLUOROURACIL (5-FU) IN PATIENTS (PTS) WITH ADVANCED NEUROENDOCRINE TUMORS (NET)
Authors: PAPAMICHAEL D PENSON RT SEYMOUR MT WILSON P GALLAGHER CJ BESSER GM SLEVIN ML
Citation: D. Papamichael et al., A PHASE-II STUDY OF INTERFERON ALPHA-2A (IFN-ALPHA) AND MODULATED 5-FLUOROURACIL (5-FU) IN PATIENTS (PTS) WITH ADVANCED NEUROENDOCRINE TUMORS (NET), European journal of cancer, 33, 1997, pp. 1235-1235
PHASE-II STUDY OF PACLITAXEL IN PRETREATED PATIENTS WITH LOCALLY ADVANCED METASTATIC CANCER OF THE BLADDER AND URETER/
Authors: PAPAMICHAEL D GALLAGHER CJ OLIVER RTD JOHNSON PW WAXMAN J
Citation: D. Papamichael et al., PHASE-II STUDY OF PACLITAXEL IN PRETREATED PATIENTS WITH LOCALLY ADVANCED METASTATIC CANCER OF THE BLADDER AND URETER/, British Journal of Cancer, 75(4), 1997, pp. 606-607
ELUCIDATING THE ROLE OF GONADOTROPINS IN ENDOMETRIAL CANCER CELL-GROWTH
Authors: BAX CMR CHATZAKI E DAVIES S GALLAGHER CJ
Citation: Cmr. Bax et al., ELUCIDATING THE ROLE OF GONADOTROPINS IN ENDOMETRIAL CANCER CELL-GROWTH, Biochemical Society transactions, 24(3), 1996, pp. 443-443
LONG-TERM FOLLOW-UP OF GONADOTROPIN-RELEASING-HORMONE ANALOG TREATMENT FOR RECURRENT ENDOMETRIAL CANCER
Authors: JEYARAJAH AR GALLAGHER CJ BLAKE PR ORAM DH DOWSETT M FISHER C OLIVER RTD
Citation: Ar. Jeyarajah et al., LONG-TERM FOLLOW-UP OF GONADOTROPIN-RELEASING-HORMONE ANALOG TREATMENT FOR RECURRENT ENDOMETRIAL CANCER, Gynecologic oncology, 63(1), 1996, pp. 47-52
THE EXPRESSION OF GONADOTROPIN-RELEASING-HORMONE AND ITS RECEPTOR IN ENDOMETRIAL CANCER, AND ITS RELEVANCE AS AN AUTOCRINE GROWTH-FACTOR
Authors: CHATZAKI E BAX CMR EIDNE KA ANDERSON L GRUDZINSKAS JG GALLAGHER CJ
Citation: E. Chatzaki et al., THE EXPRESSION OF GONADOTROPIN-RELEASING-HORMONE AND ITS RECEPTOR IN ENDOMETRIAL CANCER, AND ITS RELEVANCE AS AN AUTOCRINE GROWTH-FACTOR, Cancer research, 56(9), 1996, pp. 2059-2065
GONADOTROPIN-RELEASING-HORMONE ANALOGUE(GNRHA) TREATMENT FOR RECURRENT PROGESTAGEN RESISTANT ENDOMETRIAL CANCER
Authors: GALLAGHER CJ ORAM DH JEYARAJAH AR OLIVER RTD BLAKE P SLEVIN M
Citation: Cj. Gallagher et al., GONADOTROPIN-RELEASING-HORMONE ANALOGUE(GNRHA) TREATMENT FOR RECURRENT PROGESTAGEN RESISTANT ENDOMETRIAL CANCER, British Journal of Cancer, 74, 1996, pp. 16-16
ANGLIAN GERM-CELL CANCER GROUP 3 V 4 COURSES AND 3 V 5 DAY EBCI BEP PILOT-STUDIES FOR METASTATIC NON-SEMINOMA(G2/3) GERM-CELL CANCER/
Authors: OLIVER RTD ONG J OSTROWSKI J WILLIAMS M WILTSHIRE C GALLAGHER CJ XU J JACKSON W BAILEYJOHNSON H PRATT W GAMBLE D MOTT M TRASK C
Citation: Rtd. Oliver et al., ANGLIAN GERM-CELL CANCER GROUP 3 V 4 COURSES AND 3 V 5 DAY EBCI BEP PILOT-STUDIES FOR METASTATIC NON-SEMINOMA(G2/3) GERM-CELL CANCER/, British Journal of Cancer, 74, 1996, pp. 29-29
WEEKLY M-BOP AS A 2ND-LINE AND VIP PLUS HIGH-DOSE AS A 3RD-LINE SALVAGE FOR GERM-CELL CANCER
Authors: OLIVER RTD ONG J GALLAGHER CJ
Citation: Rtd. Oliver et al., WEEKLY M-BOP AS A 2ND-LINE AND VIP PLUS HIGH-DOSE AS A 3RD-LINE SALVAGE FOR GERM-CELL CANCER, European journal of cancer, 31A, 1995, pp. 916-916
ACCELERATED CISPLATIN-BASED CHEMOTHERAPY FOR ADVANCED BLADDER-CANCER
Authors: BOSHOFF C OLIVER RTD GALLAGHER CJ ONG J
Citation: C. Boshoff et al., ACCELERATED CISPLATIN-BASED CHEMOTHERAPY FOR ADVANCED BLADDER-CANCER, European journal of cancer, 31A(10), 1995, pp. 1633-1636
CASTRATION-INDUCED LYMPHOCYTOSIS IN PROSTATE-CANCER - POSSIBLE EVIDENCE FOR GONAD THYMUS ENDOCRINE INTERACTION IN MAN
Authors: OLIVER RTD JOSEPH JV GALLAGHER CJ
Citation: Rtd. Oliver et al., CASTRATION-INDUCED LYMPHOCYTOSIS IN PROSTATE-CANCER - POSSIBLE EVIDENCE FOR GONAD THYMUS ENDOCRINE INTERACTION IN MAN, Urologia internationalis, 54(4), 1995, pp. 226-229
CHARACTERIZATION OF THE DIFFERENTIAL EXPRESSION OF MARKER ANTIGENS BYNORMAL AND MALIGNANT ENDOMETRIAL EPITHELIUM
Authors: CHATZAKI E GALLAGHER CJ ILES RK IND TEJ NOURI AME BAX CMR GRUDZINSKAS JG
Citation: E. Chatzaki et al., CHARACTERIZATION OF THE DIFFERENTIAL EXPRESSION OF MARKER ANTIGENS BYNORMAL AND MALIGNANT ENDOMETRIAL EPITHELIUM, British Journal of Cancer, 69(6), 1994, pp. 1010-1014
PROTRACTED ORAL ETOPOSIDE IN EPITHELIAL OVARIAN-CANCER - A PHASE-II STUDY IN PATIENTS WITH RELAPSED OR PLATINUM-RESISTANT DISEASE
Authors: SEYMOUR MT MANSI JL GALLAGHER CJ GORE ME HARPER PG EVANS TRJ EDMONDS PM SLEVIN ML
Citation: Mt. Seymour et al., PROTRACTED ORAL ETOPOSIDE IN EPITHELIAL OVARIAN-CANCER - A PHASE-II STUDY IN PATIENTS WITH RELAPSED OR PLATINUM-RESISTANT DISEASE, British Journal of Cancer, 69(1), 1994, pp. 191-195
COMBINATION CHEMOTHERAPY FOR INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA
Authors: DHALIWAL HS ROHATINER AZS GREGORY W RICHARDS MA JOHNSON PWM WHELAN JS GALLAGHER CJ MATTHEWS J GANESAN TS BARNETT MJ WAXMAN JH STANSFELD AG WRIGLEY PFM SLEVIN ML MALPAS JS LISTER TA
Citation: Hs. Dhaliwal et al., COMBINATION CHEMOTHERAPY FOR INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA, British Journal of Cancer, 68(4), 1993, pp. 767-774
Risultati: 1-15 |